Here’s what you should know.
1. While talking about the idea, Mr. Azar also said President Donald Trump could possibly go ahead and order negotiations with drug companies anyways.
2. Mr. Azar said President Trump wants to work to lower prices by merging drugs in Medicare’s part B program with drugs in Medicare’s part D program.
3. To accomplish that, legislators would have to pass a law. Mr. Azar said the idea could be explored in a demonstration project to begin with, but would eventually need a law before any widespread change could take place.
More articles on coding, billing and collections:
President Trump vows to ‘bring soaring drug prices back down to earth’ — 6 takeaways
4 new joint venture ASCs and partnerships — April/May 2018
Envision ponders sale & more — 9 ASC company key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
